Website

Contact Information:

Kirk Bennett
BMS Immuno-Oncology
612.961.4499
Kirk.bennett@bms.com

Patty Byro
BMS-Oncology
952.484.8985
Patricia.byro@bms.com

Virtual Exhibit Hall Home

Additional Information: 

Metastatic NSCLC - Treatment Options for Select Patients

Unresectable Malignant Pleural Mesothelioma - Treatment Options for Patients

Melanoma in the Metastatic Setting - Treatment Options for Patients

Completely Resected EC or GEJC in the Adjuvant Setting - Treatment Options for Patients

Gastroesophageal Cancers in both the Adjuvant and 1L Metastatic Setting - Treatment Options for Patients

aRCC - Two Treatment Options for Selected Patients

Learn About Dosing for an I-O Treatment Option (1)